Wednesday, October 31, 2012
Hyperbaric oxygenation for necrotizing soft tissue infections: pro.
Hyperbaric oxygenation for necrotizing soft tissue infections: pro.
Oct 2012
[Article in German]
Source
Klinik für Anästhesiologie und operative Intensivmedizin, Universitätsklinikum Halle (Saale), Ernst-Grube-Str. 40, 06120, Halle (Saale), Deutschland.
Abstract
Necrotizing soft tissue infections are a complex pathological spectrum of symptoms and result in a significantly increased risk of mortality depending on the degree of dissemination as well as the underlying bacterial infection. Hyperbaric oxygen therapy (HBOT) can significantly improve the effectiveness of a multidisciplinary treatment concept consisting of surgical debridement, critical care and antibiotic treatment. HBOT itself assists solid wound healing by bactericidal and bacteriostatic effects and by increasing the oxygen supply up to the cellular level resulting in an optimization of oxygen-dependent metabolic processes. The efficacy of treatment in a centre of cooperating specialized departments can therefore be increased by utilizing HBOT as adjunct treatment. Nevertheless, if a HBOT facility is available, excluding HBOT is equivalent to omission of an effective therapy option to the disadvantage of patients.
Labels: antibiotic treatment, bacterial infection, critical care, HBOT, Hyperbaric oxygen therapy, necrotizing soft tissue infections, surgical debridement
# posted by Pat O'Connor @ 8:59 AM
Saturday, September 01, 2012
Real-life 'Contagion' uses DNA to halt outbreak
Real-life 'Contagion' uses DNA to halt outbreak
August 2012
By Sharon Begley - Reuters
NEW YORK — If Hollywood needs a plot for a medical thriller, scientists at the National Institutes of Health have one: Doctors, using cutting-edge technology called whole-genome sequencing, trace an outbreak of a deadly bacterial infection, identify precisely how it's spreading - and in the final minutes sic poison-spewing robots on the rampaging microbes.
That's essentially what scientists did when Klebsiella pneumoniae, an often-lethal bacterium, spread through NIH's research hospital in Bethesda, Maryland last year, as described in a study published on Wednesday in the journal Science Translational Medicine.
"With whole-genome sequencing," said microbial geneticist Julie Segre of NIH's National Human Genome Research Institute, who led the study, "we were able to understand how the outbreak was moving through the hospital and identify weaknesses" in infection-control practices, finally halting the outbreak.
The unprecedented effort to use genome sequencing to save patients from an infectious outbreak offers hope that the technique could fight other hospital-acquired infections. These infections kill some 99,000 people die from such infections in the United States every year, estimates the U.S. Centers for Disease Control and Prevention. The added health-care costs, according to the CDC: $4.5 billion a year.
Calling it a "compelling story," virologist and microbe hunter Ian Lipkin of Columbia University in New York City said the NIH scientists' feat shows what ultra-fast whole-genome sequencing can accomplish in so-called microbial forensics. In whole-genome sequencing, machines identify the DNA units that make up an organism's entire genome.
Researchers were able "to implicate 'Patient Zero,' track transmission of a drug-resistant bacterium over the course of an important outbreak and provide insights that will inform infection control and patient care," said Lipkin, director of the Center for Infection and Immunity at Columbia's Mailman School of Public Health and a scientific adviser on the 2011 film "Contagion."
The outbreak at NIH's hospital began last summer. In June a 43-year-old patient with antibiotic-resistant K. pneumoniae, which infects the urinary tract and bloodstream and can cause sepsis, a blood infection, was transferred to its intensive-care unit from a New York City hospital. "Patient Zero" was put in an isolation room; staff and visitors had to wear gowns, masks and gloves to enter.
Labels: bacterial infection, bloodstream, DNA, genome sequencing, hospital-acquired infections, K. pneumonia, microbes, sepsis, urinary tract
# posted by Pat O'Connor @ 10:40 AM
Influence of material on the development of device-associated infections.
Influence of material on the development of device-associated infections.
July 2012
Source
AO Research Institute Davos, Davos, Switzerland.
Abstract
Clin Microbiol Infect
Keywords:
Bacterial adhesion, biocompatibility, macrophage, preclinical testing, surface chemistry, surface topography
ABSTRACT: The use of implanted devices in modern orthopaedic surgery has greatly improved the quality of life for an increasing number of patients, by facilitating the rapid and effective healing of bone after traumatic fractures, and restoring mobility after joint replacement. However, the presence of an implanted device results in an increased susceptibility to infection for the patient, owing to the creation of an immunologically compromised zone adjacent to the implant. Within this zone, the ability of the host to clear contaminating bacteria may be compromised, and this can lead to biofilm formation on the surface of the biomaterial. Currently, there are only limited data on the mechanisms behind this increased risk of infection and the role of material choice. The impacts of implant material on bacterial adhesion, immune response and infection susceptibility have been investigated individually in numerous preclinical in vitro and in vivo studies. These data provide an indication that material choice does have an impact on infection susceptibility; however, the clinical implications remain to be clearly determined.
Labels: Bacterial adhesion, bacterial infection, biocompatibility, immunologically compromised, implanted devices, macrophage, preclinical testing, surface chemistry, surface topography
# posted by Pat O'Connor @ 9:18 AM
Type I interferon and bacterial infection
Type I interferon and bacterial infection
July 2012
.
[Article in Chinese]
Source
Department of Respiratory Medicine, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China.
Abstract
Interferons (IFNs) are cytokines playing an important role in immune responses. Interferons are classified into two distinct types according to specific interferon receptors(IFNR). Type I IFNs include IFN-α and IFN-β, whereas IFN-γ is type II IFN. It is well known that type I IFNs have important roles in the host defense against viruses through activation of interferon receptor A (IFNAR). However, many recent studies have also demonstrated that type I IFNs have effects on immune responses tobacterial infection. This review focuses on the immune regulation of type I IFN-mediated signal pathways in bacterial infections such as listeria monocytogenes, streptococcus, mycobacterium tuberculosis, bacillus anthracis, legionella, pseudomonas aeruginosa and others.
Labels: bacterial infection, cytokines, IFNAR, IFNs, immune regulation, immune responses, interferon receptor A, Interferons
# posted by Pat O'Connor @ 9:12 AM
Saturday, February 18, 2012
Acute Tonsillitis.
Acute Tonsillitis.
Feb 2012
Source
62-158 CHS, Division of Head and Neck Surgery, 10833 LeConte Avenue Los Angeles, CA 90095. nshapiro@ucla.edu.
Abstract
Acute tonsillitis is an inflammatory process of the tonsillar tissues and is usually infectious in nature. Acute infections of the palatine tonsils predominantly occur in school-aged children, but patients of any age may be affected. Tonsillitis of viral origin is usually treated with supportive care. Bacterial tonsillitis is most commonly caused by Streptococcus pyogenes. Polymicrobial infections and viral pathogens are also important sources of infection. Penicillins remain the treatment of choice for S. pyogenes tonsillitis, and augmented aminopenicillins have gained utility in concert with the increasing incidence of beta-lactamase producing bacteria. We describe the anatomic features and the immunologic function of the palatine tonsils, including a detailed discussion of history and physical examination findings, treatment recommendations, and possible complications of acute tonsillitis. Establishing an accurate diagnosis and initiating appropriate treatment are key components of managing this common pathologic process.
PubMed
Labels: bacterial infection, inflammatory process, penicillin, polymicrobial infections, Streptococcus pyogenes, tonsillitis
# posted by Pat O'Connor @ 4:36 AM
